These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 30713036)
1. Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study. Downing A; Wright P; Hounsome L; Selby P; Wilding S; Watson E; Wagland R; Kind P; Donnelly DW; Butcher H; Catto JWF; Cross W; Mason M; Sharp L; Weller D; Velikova G; McCaughan E; Mottram R; Allen M; Kearney T; McSorley O; Huws DW; Brewster DH; McNair E; Gavin A; Glaser AW Lancet Oncol; 2019 Mar; 20(3):436-447. PubMed ID: 30713036 [TBL] [Abstract][Full Text] [Related]
2. Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study. Mazariego CG; Egger S; King MT; Juraskova I; Woo H; Berry M; Armstrong BK; Smith DP BMJ; 2020 Oct; 371():m3503. PubMed ID: 33028540 [TBL] [Abstract][Full Text] [Related]
3. Regional Variations in Quality of Survival Among Men with Prostate Cancer Across the United Kingdom. Donnelly DW; Gavin A; Downing A; Hounsome L; Kearney T; McNair E; Allan D; Huws DW; Wright P; Selby PJ; Kind P; Watson E; Wagland R; Wilding S; Butcher H; Mottram R; Allen M; McSorley O; Sharp L; Mason MD; Cross WR; Catto JWF; Glaser AW Eur Urol; 2019 Aug; 76(2):228-237. PubMed ID: 31060822 [TBL] [Abstract][Full Text] [Related]
4. Quality of life among symptomatic compared to PSA-detected prostate cancer survivors - results from a UK wide patient-reported outcomes study. Donnelly DW; Vis LC; Kearney T; Sharp L; Bennett D; Wilding S; Downing A; Wright P; Watson E; Wagland R; Cross WR; Mason MD; Siesling S; van Manen JG; Glaser AW; Gavin A BMC Cancer; 2019 Oct; 19(1):947. PubMed ID: 31615476 [TBL] [Abstract][Full Text] [Related]
5. Effect of investigation intensity and treatment differences on prostate cancer survivor's physical symptoms, psychological well-being and health-related quality of life: a two country cross-sectional study. Gavin AT; Donnelly D; Donnelly C; Drummond FJ; Morgan E; Gormley GJ; Sharp L BMJ Open; 2016 Dec; 6(12):e012952. PubMed ID: 27993906 [TBL] [Abstract][Full Text] [Related]
6. Patient activation and patient-reported outcomes of men from a community pharmacy lifestyle intervention after prostate cancer treatment. Lemanska A; Poole K; Manders R; Marshall J; Nazar Z; Noble K; Saxton JM; Turner L; Warner G; Griffin BA; Faithfull S Support Care Cancer; 2022 Jan; 30(1):347-358. PubMed ID: 34286350 [TBL] [Abstract][Full Text] [Related]
7. Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes. Catto JWF; Downing A; Mason S; Wright P; Absolom K; Bottomley S; Hounsome L; Hussain S; Varughese M; Raw C; Kelly P; Glaser AW Eur Urol; 2021 May; 79(5):621-632. PubMed ID: 33581875 [TBL] [Abstract][Full Text] [Related]
8. Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life. Lane A; Metcalfe C; Young GJ; Peters TJ; Blazeby J; Avery KN; Dedman D; Down L; Mason MD; Neal DE; Hamdy FC; Donovan JL; BJU Int; 2016 Dec; 118(6):869-879. PubMed ID: 27415448 [TBL] [Abstract][Full Text] [Related]
9. Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study. Ahmed HU; Hindley RG; Dickinson L; Freeman A; Kirkham AP; Sahu M; Scott R; Allen C; Van der Meulen J; Emberton M Lancet Oncol; 2012 Jun; 13(6):622-32. PubMed ID: 22512844 [TBL] [Abstract][Full Text] [Related]
10. Urinary, bowel and sexual health in older men from Northern Ireland. Donnelly DW; Donnelly C; Kearney T; Weller D; Sharp L; Downing A; Wilding S; Wright P; Kind P; Catto JWF; Cross WR; Mason MD; McCaughan E; Wagland R; Watson E; Mottram R; Allen M; Butcher H; Hounsome L; Selby P; Huws D; Brewster DH; McNair E; Rivas C; Nayoan J; Horton M; Matheson L; Glaser AW; Gavin A BJU Int; 2018 Nov; 122(5):845-857. PubMed ID: 29489050 [TBL] [Abstract][Full Text] [Related]
11. Influence of deprivation and rurality on patient-reported outcomes of men living with and beyond prostate cancer diagnosis in the UK: A population-based study. Smith L; Downing A; Norman P; Wright P; Hounsome L; Watson E; Wagland R; Selby P; Kind P; Donnelly DW; Butcher H; Huws D; McNair E; Gavin A; Glaser AW Cancer Epidemiol; 2020 Dec; 69():101830. PubMed ID: 33002843 [TBL] [Abstract][Full Text] [Related]
12. Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial. Chi KN; Protheroe A; Rodríguez-Antolín A; Facchini G; Suttman H; Matsubara N; Ye Z; Keam B; Damião R; Li T; McQuarrie K; Jia B; De Porre P; Martin J; Todd MB; Fizazi K Lancet Oncol; 2018 Feb; 19(2):194-206. PubMed ID: 29326030 [TBL] [Abstract][Full Text] [Related]
13. Symptoms, unmet needs, psychological well-being and health status in survivors of prostate cancer: implications for redesigning follow-up. Watson E; Shinkins B; Frith E; Neal D; Hamdy F; Walter F; Weller D; Wilkinson C; Faithfull S; Wolstenholme J; Sooriakumaran P; Kastner C; Campbell C; Neal R; Butcher H; Matthews M; Perera R; Rose P BJU Int; 2016 Jun; 117(6B):E10-9. PubMed ID: 25818406 [TBL] [Abstract][Full Text] [Related]
14. Symptom and function profiles of men with localized prostate cancer. Reeve BB; Tan X; Chen RC; Usinger DS; Pinheiro LC Cancer; 2018 Jul; 124(13):2832-2840. PubMed ID: 29660795 [TBL] [Abstract][Full Text] [Related]
15. Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapy. Wilding S; Downing A; Wright P; Selby P; Watson E; Wagland R; Donnelly DW; Hounsome L; Butcher H; Mason M; Henry A; Gavin A; Glaser AW Qual Life Res; 2019 Oct; 28(10):2741-2751. PubMed ID: 31115843 [TBL] [Abstract][Full Text] [Related]
16. Decision regret in men living with and beyond nonmetastatic prostate cancer in the United Kingdom: A population-based patient-reported outcome study. Wilding S; Downing A; Selby P; Cross W; Wright P; Watson EK; Wagland R; Kind P; Donnelly DW; Hounsome L; Mottram R; Allen M; Kearney T; Butcher H; Gavin A; Glaser A Psychooncology; 2020 May; 29(5):886-893. PubMed ID: 32065691 [TBL] [Abstract][Full Text] [Related]
17. Patient-Reported Functional Outcomes After Hypofractionated or Conventionally Fractionated Radiation for Prostate Cancer: A National Cohort Study in England. Nossiter J; Sujenthiran A; Cowling TE; Parry MG; Charman SC; Cathcart P; Clarke NW; Payne H; van der Meulen J; Aggarwal A J Clin Oncol; 2020 Mar; 38(7):744-752. PubMed ID: 31895608 [TBL] [Abstract][Full Text] [Related]
18. Predictors of multidomain decline in health-related quality of life after stereotactic body radiation therapy (SBRT) for prostate cancer. Dess RT; Jackson WC; Suy S; Soni PD; Lee JY; Abugharib AE; Zumsteg ZS; Feng FY; Hamstra DA; Collins SP; Spratt DE Cancer; 2017 May; 123(9):1635-1642. PubMed ID: 28001303 [TBL] [Abstract][Full Text] [Related]
19. Long-term quality of life in disadvantaged men with prostate cancer on androgen-deprivation therapy. Sevilla C; Maliski SL; Kwan L; Connor SE; Litwin MS Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):237-43. PubMed ID: 22289781 [TBL] [Abstract][Full Text] [Related]
20. Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy. Hedgepeth RC; Labo J; Zhang L; Wood DP J Urol; 2009 Jul; 182(1):221-7; discussion 227-8. PubMed ID: 19450842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]